BrightSpring officer logs equity grants, exercise and sale

BrightSpring Health Services officer Lisa A. Nalley reported several equity transactions.

(Very High)

(Negative)

Form Type

Rhea-AI Filing Summary

BrightSpring Health Services officer Lisa A. Nalley reported several equity transactions. On March 4, 2026, she exercised stock options for 30,000 shares of common stock at $6.37 per share and sold 30,000 shares in a registered public offering at $41.15 per share.

That day also reflected vesting of previously granted performance-based stock options from 2019 and 2020, which became fully vested after performance conditions were satisfied. On March 5, 2026, she received 21,354 restricted stock units and 52,344 stock options, generally vesting in three equal annual installments beginning January 25, 2027.

Insider Trade Summary

Exercise and Sale: 30,000 shares ($1.04M approx. pre-tax spread)

Exercise and Sale 7 txns

Insider Nalley Lisa A

Role See Remarks

Sold 30,000 shs ($1.23M)

Approx. gross sale proceeds $1.23M

Approx. exercise cost $191K

Approx. pre-tax spread $1.04M

Type	Security	Shares	Price	Value
Grant/Award	Stock Options (Right to Buy)	52,344	$0.00	$0.00
Grant/Award	Common Stock	21,354	$0.00	$0.00
Grant/Award	Stock Options (Right to Buy)	35,331	$0.00	$0.00
Grant/Award	Stock Options (Right to Buy)	3,925	$0.00	$0.00
Exercise	Stock Options (Right to Buy)	30,000	$0.00	$0.00
Exercise	Common Stock	30,000	$6.37	$191K
Sale	Common Stock	30,000	$41.15	$1.23M

Holdings After Transaction: Stock Options (Right to Buy) — 144,955 contracts (Direct); Common Stock — 131,948 shares (Direct)

Footnotes (6)

F1. These shares of the Issuer's common stock were sold by the Reporting Person pursuant to a registered public offering that closed on March 4, 2026, at a price of $41.15, before deducting underwriting discounts and commissions.
F2. On March 5, 2026, the Reporting Person was granted restricted stock units ("RSUs") which vest in three equal annual installments commencing on January 25, 2027. Each RSU represents a contingent right to receive one share of common stock upon settlement.
F3. No new stock options have been awarded. The transaction reported herein reflects vesting of performance-based stock options ("2019 Performance Options") previously awarded to the Reporting Person on September 24, 2019, vesting subject to performance conditions that were subsequently satisfied on March 4, 2026. The 2019 Performance Options are fully vested.
F4. No new stock options have been awarded. The transaction reported herein reflects vesting of performance-based stock options ("2020 Performance Options") previously awarded to the Reporting Person on May 12, 2020, vesting subject to performance conditions that were subsequently satisfied on March 4, 2026. The 2020 Performance Options are fully vested.
F5. These options are fully vested.
F6. Options vest in three equal annual installments commencing on January 25, 2027.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did Lisa Nalley report for BrightSpring (BTSG)?

Lisa A. Nalley reported option exercises, open-market sales, and new equity awards. She exercised 30,000 stock options, sold 30,000 common shares, and received additional stock options and 21,354 restricted stock units, reflecting both monetization and refreshed long-term incentives.

How many BrightSpring (BTSG) shares did Lisa Nalley sell and at what price?

Lisa A. Nalley sold 30,000 shares of BrightSpring common stock at $41.15 per share. The sale occurred in connection with a registered public offering that closed on March 4, 2026, before underwriting discounts and commissions were deducted from the transaction proceeds.

What option exercise did Lisa Nalley complete in this BrightSpring (BTSG) Form 4?

Lisa A. Nalley exercised 30,000 stock options into 30,000 shares of BrightSpring common stock at an exercise price of $6.37 per share. These options were derivative securities that converted into common stock as part of her equity compensation program.

What new equity awards did Lisa Nalley receive from BrightSpring (BTSG)?

Lisa A. Nalley received 21,354 restricted stock units and 52,344 stock options. The RSUs vest in three equal annual installments starting January 25, 2027, and the options also vest in three equal annual installments beginning on that same January 25, 2027 vesting date.

How are Lisa Nalley’s BrightSpring (BTSG) RSUs structured in this filing?

The restricted stock units granted to Lisa A. Nalley each represent a contingent right to receive one share of BrightSpring common stock. These RSUs vest in three equal annual installments, commencing on January 25, 2027, aligning the award with a multi-year retention and performance horizon.

Were Lisa Nalley’s older BrightSpring (BTSG) performance options affected?

Yes. Performance-based stock options originally granted in 2019 and 2020 became fully vested. The filing notes that performance conditions tied to these options were satisfied on March 4, 2026, resulting in full vesting of the 2019 and 2020 performance option awards for Lisa A. Nalley.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 03/06/2026 - 07:46 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Nalley Lisa A

(Last)

(First)

(Middle)

C/O BRIGHTSPRING HEALTH SERVICES, INC.

805 N. WHITTINGTON PARKWAY

(Street)

LOUISVILLE

40222

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
BrightSpring Health Services, Inc. [ BTSG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	See Remarks

3. Date of Earliest Transaction (Month/Day/Year)
03/04/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	03/04/2026		M		30,000	A	$6.37	140,594	D
Common Stock	03/04/2026		S⁽¹⁾		30,000	D	$41.15⁽¹⁾	110,594	D
Common Stock	03/05/2026		A⁽²⁾		21,354	A	$0	131,948	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Options (Right to Buy)	$6.37	03/04/2026		A		35,331		⁽³⁾	09/24/2029	Common Stock	35,331	$0	106,909	D
Stock Options (Right to Buy)	$7.01	03/04/2026		A		3,925		⁽⁴⁾	05/12/2030	Common Stock	3,925	$0	15,702	D
Stock Options (Right to Buy)	$6.37	03/04/2026		M			30,000	⁽⁵⁾	09/24/2029	Common Stock	30,000	$0	76,909	D
Stock Options (Right to Buy)	$41.77	03/05/2026		A		52,344		⁽⁶⁾	03/05/2036	Common Stock	52,344	$0	52,344	D

Explanation of Responses:

1. These shares of the Issuer's common stock were sold by the Reporting Person pursuant to a registered public offering that closed on March 4, 2026, at a price of $41.15, before deducting underwriting discounts and commissions.

2. On March 5, 2026, the Reporting Person was granted restricted stock units ("RSUs") which vest in three equal annual installments commencing on January 25, 2027. Each RSU represents a contingent right to receive one share of common stock upon settlement.

3. No new stock options have been awarded. The transaction reported herein reflects vesting of performance-based stock options ("2019 Performance Options") previously awarded to the Reporting Person on September 24, 2019, vesting subject to performance conditions that were subsequently satisfied on March 4, 2026. The 2019 Performance Options are fully vested.

4. No new stock options have been awarded. The transaction reported herein reflects vesting of performance-based stock options ("2020 Performance Options") previously awarded to the Reporting Person on May 12, 2020, vesting subject to performance conditions that were subsequently satisfied on March 4, 2026. The 2020 Performance Options are fully vested.

5. These options are fully vested.

6. Options vest in three equal annual installments commencing on January 25, 2027.

Remarks:

Title: Chief of Staff and Senior Vice President, Human Resources

	/s/ Jennifer Phipps, as Attorney-in-Fact	03/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

BrightSpring officer logs equity grants, exercise and sale

Rhea-AI Filing Summary

Positive

Negative